Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Maintenance Renal Transplant Patients: Pooled Results From Three International, Multicenter Studies
10.1016/j.transproceed.2006.10.216
Saved in:
Main Authors: | Pietruck, F, Abbud-Filho, M, Vathsala, A, Massari, PU, Po-Huang, L, Nashan, B |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229457 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Refractory immune thrombocytopenia in systemic lupus erythematosus: Response to mycophenolate mofetil
by: Vasoo, S., et al.
Published: (2014) -
Is a standard fixed dose of mycophenolate mofetil ideal for all patients?
by: Yau, W.-P., et al.
Published: (2014) -
Conversion to enteric-coated mycophenolate sodium from mycophenolate mofetil in stable renal transplant patients: Results of an Asia-Pacific study
by: Lee, Po-Huang, et al.
Published: (2022) -
Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression
by: Lou, HX, et al.
Published: (2022) -
Pharmacokinetic and pharmacodynamic studies of mycophenolic acid in renal transplant recipients
by: NWAY NWAY AYE
Published: (2010)